academic article

• Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk..  Cancer research.  79:505-517. 2019
• Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci..  British journal of cancer.  116:524-535. 2017
• PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS..  Journal of medical genetics.  53:800-811. 2016
• Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus..  Nature communications.  7:-. 2016
• Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types..  Cancer discovery.  :-. 2016
• A targeted genetic association study of epithelial ovarian cancer susceptibility..  Oncotarget.  7:7381-7389. 2016
• Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk..  Genetic epidemiology.  :-. 2015
• Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  :-. 2015
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer. 2015
• Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer..  Nature communications.  6:-. 2015
• Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. 2015
• Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer..  Genetic testing and molecular biomarkers.  18:229-235. 2014
• Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer..  BMC medical genomics.  7:-. 2014
• Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers..  Clinical genetics.  85:49-53. 2014
• Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer..  British journal of cancer.  107:1783-1790. 2012
• Uncertainty in the utility of immunohistochemistry in mismatch repair protein expression in epithelial ovarian cancer..  Anticancer research.  32:4963-4969. 2012
• Assessment of hepatocyte growth factor in ovarian cancer mortality..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  20:1638-1648. 2011
• Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  18:28-34. 2009
• Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans..  The Journal of urology.  175:108-12; discussion 112. 2006
• Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  15:1473-1478. 2006
• Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk..  Lung cancer (Amsterdam, Netherlands).  48:315-321. 2005